{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:04:17Z","timestamp":1794373457934,"version":"4.9.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,15]],"date-time":"2027-04-15T00:00:00Z","timestamp":1807747200000},"content-version":"am","delay-in-days":257,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2023-00223559"],"award-info":[{"award-number":["RS-2023-00223559"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.neuropharm.2026.110970","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T16:25:55Z","timestamp":1776011155000},"page":"110970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["KBN2201 attenuates A\u03b2 pathology and neuroinflammation while promoting neuroprotective and neurogenesis-related changes in a late-stage 5xFAD mouse model of Alzheimer's disease"],"prefix":"10.1016","volume":"294","author":[{"given":"Sun-Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiseo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5689-1701","authenticated-orcid":false,"given":"Moonhang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Hwan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8661-8746","authenticated-orcid":false,"given":"Joon-Suk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Ran","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-5973","authenticated-orcid":false,"given":"Sang-Rae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110970_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41582-022-00645-6","article-title":"Early-stage Alzheimer disease: getting trial-ready","volume":"18","author":"Aisen","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110970_bib2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd.2018.109","article-title":"Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing","volume":"17","author":"Boland","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2026.110970_bib3","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1080\/15548627.2016.1239003","article-title":"Autophagy flux in CA1 neurons of Alzheimer hippocampus: increased induction overburdens failing lysosomes to propel neuritic dystrophy","volume":"12","author":"Bordi","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2026.110970_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2026.110970_bib5","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1038\/s41380-025-02901-9","article-title":"Synaptic vulnerability to amyloid-\u03b2 and tau pathologies differentially disrupts emotional and memory neural circuits","volume":"30","author":"Capilla-L\u00f3pez","year":"2025","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.110970_bib6","doi-asserted-by":"crossref","first-page":"24574","DOI":"10.18632\/oncotarget.25364","article-title":"Aspirin induces autophagy via inhibition of the acetyltransferase EP300","volume":"9","author":"Castoldi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuropharm.2026.110970_bib7","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2012.02.050","article-title":"Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells","volume":"142","author":"Din","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2026.110970_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer's disease: experimental models and reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2026.110970_bib9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4103\/1673-5374.266046","article-title":"Can mouse models mimic sporadic Alzheimer's disease?","volume":"15","author":"Foidl","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2026.110970_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tins.2017.04.002","article-title":"Synaptic impairment in Alzheimer's disease: a dysregulated symphony","volume":"40","author":"Forner","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110970_bib11","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","article-title":"Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease","volume":"16","author":"Gomez-Isla","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110970_bib12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1126\/science.1215327","article-title":"The ancient drug salicylate directly activates AMP-activated protein kinase","volume":"336","author":"Hawley","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.110970_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer's disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neuropharm.2026.110970_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41583-018-0113-1","article-title":"Beyond the neuron\u2013cellular interactions in Alzheimer's disease pathology","volume":"20","author":"Henstridge","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110970_bib15","series-title":"Poster Presented at NEUROSCIENCE 2024","article-title":"Effects of KBN-2201 on pathological mechanisms of Alzheimer's disease in murine neuroblastoma Neuro2a cells","author":"Heo","year":"2024"},{"key":"10.1016\/j.neuropharm.2026.110970_bib16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110970_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","article-title":"Practical considerations for choosing a mouse model of Alzheimer's disease","volume":"12","author":"Jankowsky","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"196","key":"10.1016\/j.neuropharm.2026.110970_bib18","first-page":"e29","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2026.110970_bib19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/15548627.2022.2085496","article-title":"Pathogen-induced autophagy regulates monolignol transport and lignin formation in plant immunity","volume":"19","author":"Jeon","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2026.110970_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00401-024-02839-2","article-title":"Amyloid-\u03b2 oligomers increase the binding and internalization of tau oligomers at synapses","volume":"149","author":"Kadamangudi","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2026.110970_bib21","doi-asserted-by":"crossref","first-page":"8670","DOI":"10.1038\/s41598-020-65378-2","article-title":"A 3'UTR modification of the TNF-alpha mouse gene increases peripheral TNF-alpha and modulates the Alzheimer-like phenotype in 5XFAD mice","volume":"10","author":"Kalovyrna","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.110970_bib22","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12213","article-title":"Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019","volume":"17","author":"Knopman","year":"2021","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2026.110970_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","article-title":"The Y-Maze for assessment of spatial working and reference memory in mice","volume":"1916","author":"Kraeuter","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2026.110970_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.793328","article-title":"Selective autophagy receptor p62\/SQSTM1, a pivotal player in stress and aging","volume":"10","author":"Kumar","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2026.110970_bib25","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.celrep.2015.07.050","article-title":"Presenilin 1 maintains lysosomal Ca2+ homeostasis via TRPML1 by regulating vATPase-Mediated Lysosome acidification","volume":"12","author":"Lee","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2026.110970_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262210942","article-title":"KBN2202, a salicylic acid derivative, preserves neuronal architecture, enhances neurogenesis, attenuates amyloid and inflammatory pathology, and restores recognition memory in 5xFAD mice at an advanced stage of AD pathophysiology","volume":"26","author":"Lee","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110970_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/832704","article-title":"The role of the selective adaptor p62 and ubiquitin-like proteins in autophagy","volume":"2014","author":"Lippai","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.neuropharm.2026.110970_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrn3961","article-title":"Compromised autophagy and neurodegenerative diseases","volume":"16","author":"Menzies","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110970_bib29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41591-019-0375-9","article-title":"Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease","volume":"25","author":"Moreno-Jimenez","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2026.110970_bib30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2026.110970_bib31","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110970_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.713726","article-title":"Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study","volume":"13","author":"Oblak","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110970_bib33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110970_bib34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.14283\/jpad.2021.23","article-title":"Diagnosis of early Alzheimer's disease: Clinical practice in 2021","volume":"8","author":"Porsteinsson","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2026.110970_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-023-00651-2","article-title":"Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases","volume":"19","author":"Rinauro","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2026.110970_bib36","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2026.110970_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.110970_bib38","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.110.223883","article-title":"Lipid mediators promote resolution of acute inflammation: impact of aspirin and statins","volume":"107","author":"Spite","year":"2010","journal-title":"Circ Res Author manuscript"},{"key":"10.1016\/j.neuropharm.2026.110970_bib39","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1021\/acschemneuro.3c00149","article-title":"Neuroprotective effects of an N-Salicyloyl tryptamine derivative against cerebral ischemia\/reperfusion injury","volume":"14","author":"Su","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110970_bib40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110970_bib41","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.stem.2019.05.003","article-title":"Human hippocampal neurogenesis persists in aged adults and Alzheimer's disease patients","volume":"24","author":"Tobin","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2026.110970_bib42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.biopsych.2017.08.010","article-title":"Anti-Amyloid-beta monoclonal antibodies for Alzheimer's disease: pitfalls and promise","volume":"83","author":"van Dyck","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110970_bib43","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.110970_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.conb.2017.09.005","article-title":"Endo-lysosomal dysfunction: a converging mechanism in neurodegenerative diseases","volume":"48","author":"Wang","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110970_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2026.110970_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/procel\/pwae026","article-title":"Alzheimer's disease: insights into pathology, molecular mechanisms, and therapy","volume":"16","author":"Zheng","year":"2025","journal-title":"Protein Cell"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:04:41Z","timestamp":1778040281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826001437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":46,"alternative-id":["S0028390826001437"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110970","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KBN2201 attenuates A\u03b2 pathology and neuroinflammation while promoting neuroprotective and neurogenesis-related changes in a late-stage 5xFAD mouse model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110970"}}